ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,825Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 617

$758K Total Retail Price of All Prescriptions

Rank: 16 out of 617

662 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 662 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 662 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 588 510 1 3
SIMVASTATIN 508 454 2 2
LEVOTHYROXINE SODIUM 495 453 3 1
AMLODIPINE BESYLATE 466 446 4 6
FUROSEMIDE 409 371 5 4
METOPROLOL TARTRATE 402 365 6 11
MELOXICAM 363 314 7 24
POTASSIUM CHLORIDE 346 333 8 10
WARFARIN SODIUM 320 316 9 7
TRAMADOL HCL 304 241 10 15
ENALAPRIL MALEATE 286 265 11 34
CIPROFLOXACIN HCL 274 245 12 60
METOPROLOL SUCCINATE 261 244 13 12
ATORVASTATIN CALCIUM 224 174 14 14
METFORMIN HCL 218 192 15 9
HYDROCODONE-ACETAMINOPHEN 198 174 S3 16 8
RANITIDINE HCL 193 171 17 40
RAMIPRIL 188 147 18 67
NEXIUM 186 129 19 43
CARVEDILOL 175 149 20 19
CRESTOR 167 135 21 28
TAMSULOSIN HCL 150 136 22 26
ACETAMINOPHEN-CODEINE 149 88 S3 23 138
ZOLPIDEM TARTRATE 147 127 24 23
ADVAIR DISKUS 144 117 25 38
LOSARTAN POTASSIUM 143 118 26 22
LISINOPRIL 129 116 27 5
CELEBREX 127 125 28 63
SERTRALINE HCL 124 110 29 20
CEPHALEXIN 114 94 30 68
ALENDRONATE SODIUM 114 84 30 25
OXYCODONE-ACETAMINOPHEN 109 89 S2 32 93
ISOSORBIDE MONONITRATE ER 107 98 33 52
TRIAMTERENE-HYDROCHLOROTHIAZID 107 80 33 122
ALLOPURINOL 105 85 35 27
GABAPENTIN 102 73 36 16
CLOPIDOGREL 101 88 37 53
NAMENDA 99 99 38 35
DONEPEZIL HCL 98 98 39 30
LANSOPRAZOLE 96 87 40 213
AMITRIPTYLINE HCL 91 77 R 41 56
CYCLOBENZAPRINE HCL 90 69 R 42 74
NAPROXEN 83 67 43 101
FAMOTIDINE 79 71 44 54
SPIRONOLACTONE 77 69 45 42
DICLOFENAC SODIUM 77 67 45 98
LANTUS 76 64 47 39
PANTOPRAZOLE SODIUM 76 73 47 37
PRAMIPEXOLE DIHYDROCHLORIDE 76 76 47 153
KLOR-CON 8 74 73 50 268
PREDNISONE 73 60 51 31
CLONIDINE HCL 72 72 52 55
METOCLOPRAMIDE HCL 69 55 53 125
SYNTHROID 64 61 54 59
GEMFIBROZIL 63 47 55 105
OXYBUTYNIN CHLORIDE ER 63 63 55 114
ESCITALOPRAM OXALATE 63 52 55 65
DICYCLOMINE HCL 63 36 55 226
GLIPIZIDE 62 50 59 82
METHYLPREDNISOLONE 62 48 59 208
PLAVIX 61 54 61 86
LOSARTAN-HYDROCHLOROTHIAZIDE 57 52 62 46
IPRATROPIUM BROMIDE 53 53 63 136
POLYETHYLENE GLYCOL 3350 53 52 63 32
INSULIN SYRINGE 53 41 63 148
QUETIAPINE FUMARATE 52 46 66 78
MECLIZINE HCL 52 29 66 150
PROAIR HFA 51 34 68 75
ALBUTEROL SULFATE 50 50 69 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.